Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 (ECZema TRAlokinumab Trial no. 4)
Condition: Atopic Dermatitis Interventions: Drug: Tralokinumab; Drug: Caffeine; Drug: Warfarin; Drug: Omeprazole; Drug: Metoprolol; Drug: Midazolam Hydrochloride Sponsor: LEO Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Caffeine | Coumadin | Dermatitis | Dermatology | Eczema | Omeprazole | Pharmaceuticals | Prilosec | Toprol | Warfarin